[F18]-fluoroethylcholine combined in-line PET-CT scan for detection of lymph-node metastasis in high risk prostate cancer patients prior to radical prostatectomy: Preliminary results from a prospective histology-based study

European Journal of Cancer

Volumn 46, Issue 2, 2010, Pages 449-455

  Steuber, T ^a   Schlomm, T ^a   Heinzer, H ^a   Zacharias, M ^a   Ahyai, S ^a   Chun, K F ^a   Haese, A ^a   Klutmann, S ^a   Kollermann J ^a   Sauter, G ^a   Mester, J ^a   Mikecz, P ^b   Fisch, M ^a   Huland, H ^a   Graefen, M ^a   Salomon, G ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Extended lymphadenectomy; Imaging; Lymph node metastasis; PET CT; Prostate cancer; Staging

Indexed keywords

FLUOROETHYLCHOLINE F 18; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; CANCER PATIENT; CANCER STAGING; CLINICAL ARTICLE; CLINICAL EVALUATION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC IMAGING; DRUG EFFICACY; DRUG UPTAKE; GLEASON SCORE; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ILIAC ARTERY; ILIAC VEIN; IMAGE ANALYSIS; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MALE; NOMOGRAM; OBTURATOR NERVE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; PROSTATECTOMY; SENSITIVITY AND SPECIFICITY;

CHOLINE; FALSE NEGATIVE REACTIONS; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; POSITRON-EMISSION TOMOGRAPHY; PREOPERATIVE CARE; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RADIOPHARMACEUTICALS; RISK FACTORS; TRANSURETHRAL RESECTION OF PROSTATE;

EID: 72449183212     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2009.11.008     Document Type: Article

References (29)

1. Hull G.W., Rabbani F., Abbas F., et al. Cancer control with radical prostatectomy alone in 1,000 consecutive patients. J Urol 167 2 Pt. 1 (2002) 528-534
2. Da Pozzo L.F., Cozzarini C., Briganti A., et al. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy. Eur Urol 55 5 (2009) 1003-1011
3. Boorjian S.A., Thompson R.H., Siddiqui S., et al. Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era. J Urol 178 3 Pt. 1 (2007) 864-870 [discussion 870-1]
4. Messing E.M., Manola J., Yao J., et al. Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy. Lancet Oncol 7 6 (2006) 472-479
5. Hovels A.M., Heesakkers R.A., Adang E.M., et al. The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis. Clin Radiol 63 4 (2008) 387-395
6. Mattei A., Fuechsel F.G., Bhatta Dhar N., et al. The template of the primary lymphatic landing sites of the prostate should be revisited: results of a multimodality mapping study. Eur Urol 53 1 (2008) 118-125
7. Jeschke S., Beri A., Grull M., et al. Laparoscopic radioisotope-guided sentinel lymph node dissection in staging of prostate cancer. Eur Urol 53 1 (2008) 126-132
8. Harisinghani M.G., Barentsz J., Hahn P.F., et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. New Engl J Med 348 25 (2003) 2491-2499
9. Sciarra A., Panebianco V., Salciccia S., et al. Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer. Eur Urol 54 3 (2008) 589-600
10. de Jong I.J., Pruim J., Elsinga P.H., Vaalburg W., and Mensink H.J. Preoperative staging of pelvic lymph nodes in prostate cancer by 11C-choline PET. J Nucl Med 44 3 (2003) 331-335
11. Fricke E., Machtens S., Hofmann M., et al. Positron emission tomography with 11C-acetate and 18F-FDG in prostate cancer patients. Eur J Nucl Med Mol Imaging 30 4 (2003) 607-611
12. Hara T., Kosaka N., and Kishi H. Development of (18)F-fluoroethylcholine for cancer imaging with PET: synthesis, biochemistry, and prostate cancer imaging. J Nucl Med 43 2 (2002) 187-199
13. Schiavina R., Scattoni V., Castellucci P., et al. 11C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms. Eur Urol 54 2 (2008) 392-401
14. Hacker A., Jeschke S., Leeb K., et al. Detection of pelvic lymph node metastases in patients with clinically localized prostate cancer: comparison of [18F]fluorocholine positron emission tomography-computerized tomography and laparoscopic radioisotope guided sentinel lymph node dissection. J Urol 176 5 (2006) 2014-2018 [discussion 2018-9]
15. Husarik D.B., Miralbell R., Dubs M., et al. Evaluation of [(18)F]-choline PET/CT for staging and restaging of prostate cancer. Eur J Nucl Med Mol Imaging 35 2 (2008) 253-263
16. Briganti A., Chun F.K., Salonia A., et al. Validation of a nomogram predicting the probability of lymph node invasion among patients undergoing radical prostatectomy and an extended pelvic lymphadenectomy. Eur Urol 49 6 (2006) 1019-1026 [discussion 1026-7]
17. Epstein J.I., Allsbrook Jr. W.C., Amin M.B., and Egevad L.L. The 2005 international society of urological pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma. Am J Surg Pathol 29 9 (2005) 1228-1242
18. Graefen M., Walz J., and Huland H. Open retropubic nerve-sparing radical prostatectomy. Eur Urol 49 1 (2006) 38-48
19. McNeal J.E., Redwine E.A., Freiha F.S., and Stamey T.A. Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol 12 12 (1988) 897-906
20. Greene F.L., and Sobin L.H. The TNM system: our language for cancer care. J Surg Oncol 80 3 (2002) 119-120
21. Cagiannos I., Karakiewicz P., Eastham J.A., et al. A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer. J Urol 170 5 (2003) 1798-1803
22. Yoshimoto M., Waki A., Obata A., et al. Radiolabeled choline as a proliferation marker: comparison with radiolabeled acetate. Nucl Med Biol 31 7 (2004) 859-865
23. DeGrado T.R., Coleman R.E., Wang S., et al. Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer. Cancer Res 61 1 (2001) 110-117
24. Budiharto T.J.S., Lerut E., Haustermans K., et al. Evaluation of Choline (Chol) PET CT and diffusion weighted (DW) MRI for the nodal staging of Prostate Cancer (PCa) with a high risk of lymph node (LN) metastases. Eur Urol Suppl. 8 4 (2009) 121-416
25. Schumacher D.S.J., Brekkan E., Wassberg C., and Malmström P.U. The value of C11-acetate PET for Lymph node staging in patients with newly diagnosed prostate cancer - results of a prospective study. Eur Urol Suppl 8 4 (2009) 121-416
26. Scattoni V., Picchio M., Suardi N., et al. Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy. Eur Urol 52 2 (2007) 423-429
27. Schilling D., Schlemmer H.P., Wagner P.H., et al. Histological verification of 11C-choline-positron emission/computed tomography-positive lymph nodes in patients with biochemical failure after treatment for localized prostate cancer. BJU Int 102 4 (2008) 446-451
28. Rinnab L., Mottaghy F.M., Blumstein N.M., et al. Evaluation of [11C]-choline positron-emission/computed tomography in patients with increasing prostate-specific antigen levels after primary treatment for prostate cancer. BJU Int 100 4 (2007) 786-793
29. Stephenson A.J., Scardino P.T., Kattan M.W., et al. Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. J Clin Oncol 25 15 (2007) 2035-2041